Biolase Receives Eye Treatment Patent
IRVINE, Calif., Sept. 12, 2011 — Dental laser manufacturer Biolase Technology Inc. has received US Patent No. 7,997,279, titled “Methods for Treating Eye Conditions,” from the US Patent and Trademark Office, the company announced recently.
The new patent is the 13th issued in the ophthalmic family, with 20 others pending. It continues and expands US Patent No. 7,665,467, with broad claims covering the use of laser technology for treating various conditions of the eye, including presbyopia — the inability to focus sharply for near vision — and it opens up opportunities in oculoplastics as well as the treatment of cataracts and glaucoma.
In other news, the company has formed a Oculase Inc., a wholly owned subsidiary based in Delaware. The new entity will own and develop the company’s ophthalmic assets and technologies. Biolase said it plans to develop an operating unit at the new venture to focus specifically on diseases and conditions of the eye.
For more information, visit: www.biolase.com
/Buyers_Guide/BIOLASE_Inc/c1774
Published: September 2011
Glossary
- ophthalmology
- Ophthalmology is a branch of medicine that focuses on the anatomy, physiology, and diseases of the eyes and visual system. Ophthalmologists are medical doctors who specialize in the diagnosis, treatment, and prevention of eye disorders and diseases. They are trained to provide comprehensive eye care, including medical, surgical, and optical interventions.
Key areas within ophthalmology include:
General eye care: Ophthalmologists perform routine eye examinations to assess visual acuity,...
- presbyopia
- A state in which the human eye has very little or no power of accommodation. A common and normal condition in the eyes of those age 50 and older.
Americasbiolase technologyBiophotonicsBusinessCaliforniacataractsDelawaredental laserseye diseaseglaucomaOculaseoculoplasticsophthalmic stentsophthalmologypresbyopiaUS Patent No. 7665467US Patent No. 7997279Lasers